MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the appointment of Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., as executive vice president and chief medical officer, oncology, and Hassan Movahhed as vice president of clinical operations, oncology. Dr. Kelsey will manage the operational and strategic activities of the company’s oncology programs. He will report to Dr. Thomas B. Okarma, Geron’s president and chief executive officer. Mr. Hassan will be responsible for all oncology clinical operations and will report to Dr. Kelsey.
